46 related articles for article (PubMed ID: 26411101)
1. DNA content and clinicopathological features aid in distinguishing ameloblastic carcinoma from ameloblastoma.
Penafort PVM; Rocha AC; Mariano FV; Dos Santos JN; Oliveira MC; Vargas PA; Sperandio M
J Oral Pathol Med; 2024 Jan; 53(1):70-78. PubMed ID: 38163857
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of NM23 protein in ameloblastoma and ameloblastic carcinoma: An immunohistochemical study.
Ladeji A; Olatunji S; Adebiyi K; Olajide M; Kuye O; Aborisade A
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101532. PubMed ID: 37295743
[TBL] [Abstract][Full Text] [Related]
3. Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses.
Hurník P; Putnová BM; Ševčíková T; Hrubá E; Putnová I; Škarda J; Havel M; Res O; Cvek J; Buchtová M; Štembírek J
BMC Oral Health; 2023 Aug; 23(1):563. PubMed ID: 37573343
[TBL] [Abstract][Full Text] [Related]
4. Adenoid 'ameloblastoma': Clinicopathological description of 4 additional BRAF-negative cases.
Khalaj F; Cinel L; Aminishakib P; Mosavat F; Soluk-Tekkesin M
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101585. PubMed ID: 37543210
[TBL] [Abstract][Full Text] [Related]
5. Deep learning applied to the histopathological diagnosis of ameloblastomas and ameloblastic carcinomas.
Giraldo-Roldan D; Ribeiro ECC; Araújo ALD; Penafort PVM; Silva VMD; Câmara J; Pontes HAR; Martins MD; Oliveira MC; Santos-Silva AR; Lopes MA; Kowalski LP; Moraes MC; Vargas PA
J Oral Pathol Med; 2023 Nov; 52(10):988-995. PubMed ID: 37712132
[TBL] [Abstract][Full Text] [Related]
6. Revisiting Vickers and Gorlin criteria in histopathological subtypes of ameloblastoma.
Adyanthaya S; Begum S; Devasia J; Sasikumar R; Smitha T; Abdulla R
J Oral Maxillofac Pathol; 2023; 27(3):455-460. PubMed ID: 38033969
[TBL] [Abstract][Full Text] [Related]
7. Peripheral desmoplastic ameloblastoma in adolescent age: clinico-pathological and immunohistochemical analisys of a case.
Oteri G; Lentini M; Pisano M; Cicciù M
Open Dent J; 2014; 8():159-63. PubMed ID: 25317210
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Prevalence and Clinical Features of Ameloblastoma and its Histopathological Subtypes in Southeast Myanmar and Lower Northern Thailand Populations: A 13-Year Retrospective Study.
Intapa C
J Clin Diagn Res; 2017 Jan; 11(1):ZC102-ZC106. PubMed ID: 28274056
[TBL] [Abstract][Full Text] [Related]
9. Time to Recurrence of Ameloblastoma and Associated Factors in a Multi-institutional Black Patient Cohort.
Akinshipo AO; Shanti RM; Adisa AO; Effiom OA; Adebiyi KE; Carrasco LR; Kaleem A; Arotiba GT; Akintoye SO
J Racial Ethn Health Disparities; 2024 Feb; ():. PubMed ID: 38324239
[TBL] [Abstract][Full Text] [Related]
10. Basal cell ameloblastoma-review of literature with report of three cases.
Giraddi GB; Anusha AS
J Oral Biol Craniofac Res; 2012; 2(1):53-6. PubMed ID: 25756034
[TBL] [Abstract][Full Text] [Related]
11. Rare giant granular cell ameloblastoma: a case report and an immunohistochemical study.
Hunasgi S; Koneru A; Chauhan DS; Guruprasad Y
Case Rep Dent; 2013; 2013():372781. PubMed ID: 23533826
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies in ameloblastomas and amelobastic carcinoma-A systematic review.
Bologna-Molina R; Schuch L; Magliocca K; van Heerden W; Robinson L; Bilodeau EA; Hussaini HM; Soluk-Tekkesin M; Adisa AO; Tilakaratne WM; Li J; Gomez RS; Hunter KD
Oral Dis; 2024 May; ():. PubMed ID: 38693620
[TBL] [Abstract][Full Text] [Related]
13. Growth rate per year of a soft tissue recurrent ameloblastoma.
Martins Chaves RR; Castro WH; Gomez RS
Clin Case Rep; 2024 Jan; 12(1):e8444. PubMed ID: 38259867
[TBL] [Abstract][Full Text] [Related]
14. Granularity in granular cell ameloblastoma.
Yamunadevi A; Madhushankari GS; Selvamani M; Basandi PS; Yoithapprabhunath TR; Ganapathy N
J Pharm Bioallied Sci; 2014 Jul; 6(Suppl 1):S16-20. PubMed ID: 25210361
[TBL] [Abstract][Full Text] [Related]
15. Comment on "'Collision Tumour' Involving Desmoplastic Ameloblastoma and Squamous Odontogenic Tumour: Diagnostic Precision and Implications" - A Need for Reevaluation of Histopathological Findings.
Cunha JLS
Indian J Otolaryngol Head Neck Surg; 2024 Apr; 76(2):2182-2183. PubMed ID: 38566722
[No Abstract] [Full Text] [Related]
16. Immunohistochemical Expression of MMP-9 and E-Cadherin in subtypes of Ameloblastoma.
Farhan F; Niazi Z; Masood S; Abbas B
Pak J Med Sci; 2022; 38(1):207-213. PubMed ID: 35035427
[TBL] [Abstract][Full Text] [Related]
17. IMMUNOEXPRESSION OF TWIST IN DIFFERENT MORPHOLOGICAL VARIANTS OF AMELOBLASTOMAS.
Khalil E; Rehman A; Ahmed F
J Ayub Med Coll Abbottabad; 2015; 27(2):296-303. PubMed ID: 26411101
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry.
Müller S; DeRose PB; Cohen C
Arch Pathol Lab Med; 1993 Nov; 117(11):1126-31. PubMed ID: 8239934
[TBL] [Abstract][Full Text] [Related]
19. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.
Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS
Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
